However, the presence of a high-risk IL-6 promoter genotype was significantly associated with increased risk of relapsed breast cancer in a univariate conditional logistic regression model (OR 2.35, 95% CI 1.16–4.77, p = 0.018). This evidence concerns the gene IL6 and breast carcinoma.